Patent intelligence · US
US 9278088
Methods for identifying analgesic agents
Methods for identifying analgesic agents
Patent details — US 9278088
- Jurisdiction
- US
- Status
- granted
- Grant date
- Mar 8, 2016
- Expiration
- Mar 3, 2036
- Applicant
- Xenon Pharmaceuticals Inc.
- Claims
- 4
- CPC classes
- A61K, A61K31/40, A61K31/407
Quick answer
US 9278088 (Methods for identifying analgesic agents) is held by Xenon Pharmaceuticals Inc.. Status: granted. Granted Mar 8, 2016. Expires Mar 3, 2036 (10 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Expiration
- Claims
- 4
- CPC classes
- A61K, A61K31/40, A61K31/407
More from Xenon Pharmaceuticals Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12319657
Solid state crystalline forms of a selective potassium channel modulator
granted -
US 12178811
Methods of treating depressive disorders
granted -
US 12171759
Methods and uses for treating anhedonia
granted -
US 11957675
Methods and uses for treating anhedonia
granted -
US 11325902
Benzenesulfonamide compounds and their use as therapeutic agents
granted -
US 11299490
Benzenesulfonamide compounds and their use as therapeutic agents
granted -
US 11203572
Substituted benzamides and methods of use thereof
granted -
US 11174268
Benzenesulfonamide compouds and their use as therapeutic agents
granted
Frequently asked questions
What is US patent 9278088?
US 9278088 (Methods for identifying analgesic agents) is held by Xenon Pharmaceuticals Inc.. Status: granted. Granted Mar 8, 2016. Expires Mar 3, 2036 (10 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9278088?
Xenon Pharmaceuticals Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 106 pharmaceutical patents for this assignee.
When does US 9278088 expire?
Our index shows an expiration date of Mar 3, 2036 (10 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.